Pharmaceutical stocks such as Eli Lilly rise after President Donald Trump announces a 100% tariff on drug products from companies not building manufacturing plants in the U.S.
The latest example is expected to come in the form of what Trump called a “tremendous fee” the U.S. will collect for its part in negotiating an agreement to spin off the Chine ...
Trade Desk has struggled to keep up with the broader S&P 500 Index over the past year, but analysts are fairly bullish on its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback